Literature DB >> 7497833

Morbidity of subtotal colectomy in patients with severe ulcerative colitis unresponsive to cyclosporin.

P R Fleshner1, F Michelassi, M Rubin, S B Hanauer, S E Plevy, S R Targan.   

Abstract

PURPOSE: The aim of this study was to document the morbidity of urgent subtotal colectomy and ileostomy in patients with severe ulcerative colitis who failed cyclosporin treatment.
METHODS: We reviewed the charts of patients with severe ulcerative colitis who did not respond to cyclosporin treatment and underwent urgent subtotal colectomy and Brooke ileostomy at two inflammatory bowel disease centers over the 12-month period ending April 1994.
RESULTS: Fourteen patients (6 males; mean age, 34 years) required an urgent subtotal colectomy and Brooke ileostomy after failing treatment with cyclosporin. There were no deaths. Eight patients (57 percent) developed post-operative complications, which included ileus (3), deep vein thrombosis (2), wound infection (2), and partial dehiscence of rectal stump (1). Mean length of postoperative hospital stay was 8.8 days.
CONCLUSIONS: These initial data suggest that cyclosporin treatment may not influence the safety of urgent surgical treatment in severe ulcerative colitis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7497833     DOI: 10.1007/bf02049146

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  9 in total

Review 1.  Recent advances in the diagnosis and classification of inflammatory bowel disease.

Authors:  Eric Vasiliauskas
Journal:  Curr Gastroenterol Rep       Date:  2003-12

2.  Leukocyte removal therapy for ulcerative colitis does not affect postoperative complications.

Authors:  Hiroki Ikeuchi; Takehira Yamamura; Masato Kusunoki; Hiroki Nakano; Motoi Uchino; Mitsuhiro Nakamura; Masafumi Noda; Hidenori Yanagi; Takayuki Matsumoto
Journal:  J Gastroenterol       Date:  2006-09       Impact factor: 7.527

3.  Surgical site infection following surgery for inflammatory bowel disease in patients with clean-contaminated wounds.

Authors:  Motoi Uchino; Hiroki Ikeuchi; Toshie Tsuchida; Kazuhiko Nakajima; Naohiro Tomita; Yoshio Takesue
Journal:  World J Surg       Date:  2009-05       Impact factor: 3.352

Review 4.  Inflammatory bowel disease: perioperative pharmacological considerations.

Authors:  Ajay Kumar; Moises Auron; Ashish Aneja; Franziska Mohr; Alok Jain; Bo Shen
Journal:  Mayo Clin Proc       Date:  2011-08       Impact factor: 7.616

Review 5.  Colectomy in patients with acute colitis: a systematic review.

Authors:  P H E Teeuwen; M W J Stommel; A J A Bremers; G J van der Wilt; D J de Jong; R P Bleichrodt
Journal:  J Gastrointest Surg       Date:  2009-01-09       Impact factor: 3.452

6.  Skin manifestations of inflammatory bowel disease.

Authors:  Brian L Huang; Stephanie Chandra; David Quan Shih
Journal:  Front Physiol       Date:  2012-02-06       Impact factor: 4.566

7.  Endoscopic treatment for repeated arterial bleeding with ulcerative colitis.

Authors:  Tadayuki Oshima; Takashi Joh; Hiromi Kataoka; Makoto Sasaki; Fumitaka Fujita; Shozo Togawa; Tsuneya Wada; Etsuko Iio; Makoto Itoh
Journal:  Dig Dis Sci       Date:  2007-04-03       Impact factor: 3.487

8.  Perioperative use of immunosuppressive medications in patients with Crohn's disease in the new "biological era".

Authors:  Amy L Lightner; Bo Shen
Journal:  Gastroenterol Rep (Oxf)       Date:  2017-04-07

Review 9.  Perioperative Management of Patients with Inflammatory Rheumatic Diseases Undergoing Major Orthopaedic Surgery: A Practical Overview.

Authors:  Roberta Gualtierotti; Marco Parisi; Francesca Ingegnoli
Journal:  Adv Ther       Date:  2018-03-20       Impact factor: 3.845

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.